Explore groundbreaking research on pancreatic cancer treatment that shows promise in inducing complete tumour regression.

Explore how claudin-18.2 can transform cancer treatment for gastric and pancreatic tumours using targeted radiotherapy.

A University of Kentucky Markey Cancer Center study shows that a targeted form of radiation therapy can be safely delivered ...

Targeted therapies are cancer medications that work more selectively than standard chemotherapy medications. They do this by targeting specific molecules or genetic changes in cancer cells in order to ...

The FDA has granted priority review to the new drug application (NDA) for gedatolisib, a first-in-class multi-target PI3K/mTOR inhibitor, for hormone receptor–positive/HER2-negative, PIK3CA wild-type ...

For the past 20 years, many of the dramatic improvements in cancer outcomes can be attributed to personalized cancer treatments based upon DNA mutations in a tumor. Targeted therapies — often one pill ...

Gedatolisib's NDA for advanced breast cancer treatment has been accepted by the FDA, with a priority review and a PDUFA date ...

Targeted therapies are medicines to treat cancer. They work differently than standard chemotherapy. Instead of killing all fast-growing cells or keeping them from dividing, targeted therapies work ...

Focal therapy now helping in the fight against prostate cancer With focal therapy, doctors are now able to destroy cancer cells without damaging the surrounding nerves and tissue. In today’s ...

A $10 million grant by retired biotechnology leader and trustee board member Henri A. Termeer will help Massachusetts General Hospital in Boston build the Henri and Belinda Termeer Center for Targeted ...